ClassID:

95252

C07D403/12 - page 14 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3901
20150225396
2015-08-13

Quinazolinone compounds and derivatives thereof

#3902
20150225381
2015-08-13

Imidazoline derivatives, preparation methods thereof, and their applications in medicine

#3903
20150225377
2015-08-13

VEGFR3 INHIBITORS

#3904
20150225373
2015-08-13

KINASE INHIBITORS

#3905
20150225342
2015-08-13

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

#3906
20150223460
2015-08-13

Tetrazolinone compounds and their use as pesticides

#3907
20150218380
2015-08-06

Modified carbocyanine dyes and their conjugates

#3908
20150218182
2015-08-06

Modulators of virus assembly as antiviral agents

#3909
20150218154
2015-08-06

Phosphatidylinositol 3-kinase inhibitors

#3910
20150218151
2015-08-06

Phenylacetamide compound and pharmaceutical containing same

#3911
20150218137
2015-08-06

Pyrazolyl-ureas as kinase inhibitors

#3912
20150218131
2015-08-06

Pyrazole carboxamide compounds and uses thereof

#3913
20150218093
2015-08-06

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists

#3914
20150218092
2015-08-06

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists

#3915
20150210690
2015-07-30

Neprilysin inhibitors

#3916
20150210678
2015-07-30

N-cycloalkyl-N-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives

#3917
20150210676
2015-07-30

Tricyclic amidine derivatives as HIV attachment inhibitors

#3918
20150210670
2015-07-30

Uracil derivatives as AXL and c-MET kinase inhibitors

#3919
20150210640
2015-07-30

1-(cycloalkyl-carbonyl)proline derivative

#3920
20150209358
2015-07-30

Uracil derivatives as AXL and c-MET kinase inhibitors

#3921
20150209352
2015-07-30

Neprilysin inhibitors

#3922
20150209351
2015-07-30

Alpha adrenergic receptor modulators

#3923
20150206734
2015-07-23

Method and manufacturing system

#3924
20150203511
2015-07-23

Tetrazolinone compounds and their use as pesticides

#3925
20150203480
2015-07-23

Guanidine compound

#3926
20150203479
2015-07-23

Androgen receptor modulating compounds

#3927
20150203473
2015-07-23

Method of synthesizing thyroid hormone analogs and polymorphs thereof

#3928
20150203450
2015-07-23

Indole and azaindole derivative having AMPK-activating activity

#3929
20150202240
2015-07-23

Compositions and methods for enhancing virus efficacy

#3930
20150197514
2015-07-16

Pesticidal compositions and processes related thereto

#3931
20150197511
2015-07-16

Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents

#3932
20150197509
2015-07-16

Substituted sulfonamide compounds

#3933
20150197496
2015-07-16

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#3934
20150196672
2015-07-16

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#3935
20150191487
2015-07-09

Tetrazole-substituted arylamides as P2Xand P2Xantagonists

#3936
20150191483
2015-07-09

Pyrrolidinyl sulfone RORγ modulators

#3937
20150191461
2015-07-09

Pyrazolyl derivatives as Syk inhibitors

#3938
20150191460
2015-07-09

N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof

#3939
20150191458
2015-07-09

Triazole carboxamides and uses thereof

#3940
20150191436
2015-07-09

-sulfonyl-5-fluoropyrimidinone derivatives

#3941
20150190457
2015-07-09

Pyrrolidine derivatives and their use as complement pathway modulators

#3942
20150190395
2015-07-09

Substituted imidazoles as PDE10A inhibitors

#3943
20150183824
2015-07-02

Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including β-amino acids prepared via Mukaiyama aldol addition

#3944
20150183775
2015-07-02

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#3945
20150183763
2015-07-02

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

#3946
20150175657
2015-06-25

HCV protease inhibitors and uses thereof

#3947
20150175626
2015-06-25

Synthesis of an antiviral compound

#3948
20150175601
2015-06-25

Substituted quinazolines for inhibiting kinase activity

#3949
20150175599
2015-06-25

FAAH inhibitors

#3950
20150175592
2015-06-25

Viral polymerase inhibitors

#3951
20150175588
2015-06-25

N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides

#3952
20150175582
2015-06-25

Synthesis of novel inhibitors of isoprenoid biosynthesis

#3953
20150175576
2015-06-25

Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety

#3954
20150175575
2015-06-25

Imidazolyl analogs as syk inhibitors

#3955
20150175557
2015-06-25

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

#3956
20150175555
2015-06-25

Pyridazine compounds, compositions and methods

#3957
20150173359
2015-06-25

SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES

#3958
20150166591
2015-06-18

METHODS AND COMPOSITIONS FOR RAF KINASE MEDIATED DISEASES

#3959
20150166578
2015-06-18

Pyrrolidine derivatives and their use as complement pathway modulators

#3960
20150166564
2015-06-18

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

#3961
20150166543
2015-06-18

Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation

#3962
20150166526
2015-06-18

Modulators of calcium release-activated calcium channel

#3963
20150166523
2015-06-18

BRANCHED CHAIN ALKYL HETEROAROMATIC RING DERIVATIVE

#3964
20150166513
2015-06-18

Heterocyclyl pyrimidine analogues as TYK2 inhibitors

#3965
20150166508
2015-06-18

Compounds

#3966
20150166486
2015-06-18

Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors

#3967
20150164876
2015-06-18

Compounds and methods for inhibiting phosphate transport

#3968
20150164861
2015-06-18

Autotaxin inhibitors and uses thereof

#3969
20150159288
2015-06-11

Additives for electroplating baths

#3970
20150158865
2015-06-11

Inhibitors of Bruton's tyrosine kinase

#3971
20150158851
2015-06-11

PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

#3972
20150158828
2015-06-11

Heterocyclic compounds useful for kinase inhibition

#3973
20150158824
2015-06-11

Compositions and methods for inhibition of the JAK pathway

#3974
20150158823
2015-06-11

2,4-Pyrimidinediamine compounds and their uses

#3975
20150158819
2015-06-11

Neprilysin inhibitors

#3976
20150157684
2015-06-11

Soft protease inhibitors and pro-soft forms thereof

#3977
20150157629
2015-06-11

Type II RAF kinase inhibitors

#3978
20150152089
2015-06-04

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

#3979
20150152088
2015-06-04

ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF

#3980
20150152087
2015-06-04

Monocyclic heteroaryl cycloalkyldiamine derivatives

#3981
20150152069
2015-06-04

N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer

#3982
20150152068
2015-06-04

Amino pyrimidine derivatives

#3983
20150152041
2015-06-04

Benzathine analogs

#3984
20150150874
2015-06-04

JAK kinase modulating compounds and methods of use thereof

#3985
20150150257
2015-06-04

Pyrazole compound and pesticidal mixtures comprising a pyrazole compound

#3986
20150148358
2015-05-28

DGAT2 inhibitors

#3987
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#3988
20150141646
2015-05-21

Drug-conjugates, conjugation methods, and uses thereof

#3989
20150141443
2015-05-21

Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof

#3990
20150141433
2015-05-21

N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A

#3991
20150141392
2015-05-21

Substituted macrocyclic compounds having proteasome inhibitory activity

#3992
20150140104
2015-05-21

Therapeutic polymeric nanoparticles and methods of making and using same

#3993
20150133473
2015-05-14

Ring-substituted N-pyridinyl amides as kinase inhibitors

#3994
20150133471
2015-05-14

Compounds and their use as BACE inhibitors

#3995
20150133457
2015-05-14

Heterocyclic compounds and uses thereof

#3996
20150133441
2015-05-14

Theramutein modulators

#3997
20150133439
2015-05-14

QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS

#3998
20150126737
2015-05-07

Method for producing triazinyl-substituted oxindoles

#3999
20150126570
2015-05-07

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#4000
20150126563
2015-05-07

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

#4001
20150126550
2015-05-07

Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives

#4002
20150126504
2015-05-07

2,4-pyrimidinediamine compounds and their uses

#4003
20150126500
2015-05-07

Piperazinyl pyrimidine derivatives, preparation method and use thereof

#4004
20150126499
2015-05-07

Triazole compounds that modulate HSP90 activity

#4005
20150126492
2015-05-07

Complement pathway modulators and uses thereof

#4006
20150126484
2015-05-07

Aminopyrimidine derivatives for use as modulators of kinase activity

#4007
20150119405
2015-04-30

Inhibitors of the fibroblast growth factor receptor

#4008
20150119362
2015-04-30

Heteroaryl inhibitors of PDE4

#4009
20150112065
2015-04-23

Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative

#4010
20150111893
2015-04-23

Nuclear transport modulators and uses thereof

#4011
20150111890
2015-04-23

ISOINDOLONE DERIVATIVES

#4012
20150111889
2015-04-23

Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists

#4013
20150111875
2015-04-23

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#4014
20150111874
2015-04-23

Heterocyclic compounds and uses thereof

#4015
20150111857
2015-04-23

Compositions useful for treating disorders related to kit

#4016
20150111750
2015-04-23

Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)hetarylcarboxamide compounds and their use as herbicides

#4017
20150105549
2015-04-16

Intermediates to prepare herbicidal pyrimidone derivatives

#4018
20150105539
2015-04-16

Drug-conjugates, conjugation methods, and uses thereof

#4019
20150105403
2015-04-16

Estrogen receptor modulators and uses thereof

#4020
20150105389
2015-04-16

3,5-diaminopyrazole kinase inhibitors

#4021
20150105385
2015-04-16

Heterocyclic compounds and uses thereof

#4022
20150105378
2015-04-16

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#4023
20150105375
2015-04-16

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#4024
20150105354
2015-04-16

Heterocyclic aspartyl protease inhibitors

#4025
20150105351
2015-04-16

Compounds and methods for treating HIV infections

#4026
20150105253
2015-04-16

N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide salts and use thereof as herbicides

#4027
20150099770
2015-04-09

Carboxylic acid compounds

#4028
20150099756
2015-04-09

Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2

#4029
20150099740
2015-04-09

Treatment of central nervous system disorders

#4030
20150099734
2015-04-09

Diazaspirocycloalkane and azaspirocycloalkane

#4031
20150099728
2015-04-09

Substituted phenylureas and phenylamides as vanilloid receptor ligands

#4032
20150099696
2015-04-09

Compounds for the treatment of dyslipidemia and related diseases

#4033
20150094465
2015-04-02

N-alkoxyamide conjugates as imaging agents

#4034
20150094311
2015-04-02

NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS

#4035
20150094304
2015-04-02

Modulators of ATP-Binding Cassette Transporters

#4036
20150094298
2015-04-02

Inhibitors of protein kinases

#4037
20150094295
2015-04-02

Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

#4038
20150094283
2015-04-02

COMBINATION

#4039
20150094275
2015-04-02

Small molecule myristate inhibitors of Bcr-abl and methods of use

#4040
20150094205
2015-04-02

5-aminopyrimidine derivatives and use thereof for combating undesired plant growth

#4041
20150087835
2015-03-26

Process for the preparation of vilazodone hydrochloride and its amorphous form

#4042
20150087832
2015-03-26

PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES

#4043
20150087664
2015-03-26

Substituted quinazolines as serine/threonine kinase inhibitors

#4044
20150087646
2015-03-26

Triazolone compounds as mPGES-1 inhibitors

#4045
20150087639
2015-03-26

Nitrogenous heterocyclic derivatives and their application in drugs

#4046
20150087513
2015-03-26

Substituted [1,2,4]triazoles and substituted tetrazoles as herbicides

#4047
20150080568
2015-03-19

Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitors

#4048
20150080434
2015-03-19

Phenyl and benzodioxinyl substituted indazoles derivatives

#4049
20150080408
2015-03-19

Substituted biphenyl amides as P2Xand P2Xantagonists

#4050
20150080398
2015-03-19

3,5-diaminopyrazole kinase inhibitors

#4051
20150080397
2015-03-19

Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors

#4052
20150080382
2015-03-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#4053
20150080375
2015-03-19

Kinase inhibitors

#4054
20150080368
2015-03-19

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#4055
20150080364
2015-03-19

Carbamate compounds and of making and using same

#4056
20150079625
2015-03-19

Naphthalene-based two-photon fluorescent probes, preparation method and use thereof

#4057
20150079000
2015-03-19

Labelled Quinoxaline Derivatives as Multimodal Radiopharmaceuticals and Their Precursors

#4058
20150073154
2015-03-12

Discrete PEG Based Dyes

#4059
20150073139
2015-03-12

Pesticidal arylpyrrolidines

#4060
20150073136
2015-03-12

PYRAZINONE DERIVATIVES

#4061
20150072972
2015-03-12

PHTHALAZINE DERIVATIVES AS PARP INHIBITORS

#4062
20150072955
2015-03-12

Compounds for the prevention and treatment of cardiovascular diseases

#4063
20150072860
2015-03-12

Herbicidal compounds

#4064
20150065705
2015-03-05

Triazinone compound and T-type calcium channel inhibitor

#4065
20150065534
2015-03-05

Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1

#4066
20150065521
2015-03-05

TRIAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 MODULATORS

#4067
20150065505
2015-03-05

Pyrimidinone carboxamide inhibitors of endothelial lipase

#4068
20150065478
2015-03-05

Amino-derivatives as novel inhibitors of histone deacetylase

#4069
20150065468
2015-03-05

Biaryl acetamide compounds and methods of use thereof

#4070
20150065445
2015-03-05

Viral polymerase inhibitors

#4071
20150064623
2015-03-05

Compound and photosensitive resin composition

#4072
20150064171
2015-03-05

COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAEPTUC AGENTS, AND METHODS OF USE

#4073
20150057432
2015-02-26

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#4074
20150057301
2015-02-26

Pro-neurogenic compounds

#4075
20150057289
2015-02-26

Bicyclo[3.2.1]octyl amide derivatives and uses of same

#4076
20150057285
2015-02-26

Benzyl substituted triazine derivatives and their therapeutical applications

#4077
20150057273
2015-02-26

Kinase inhibitors

#4078
20150057272
2015-02-26

BENZIMIDAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS

#4079
20150057263
2015-02-26

Quinazoline compounds and their use in therapy

#4080
20150057219
2015-02-26

Reversible pegylated drugs

#4081
20150051395
2015-02-19

Sulfonamide derivative and medicinal use thereof

#4082
20150051239
2015-02-19

Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HTantagonists

#4083
20150051238
2015-02-19

Pyrazole aminopyrimidine derivatives as LRRK2 modulators

#4084
20150051201
2015-02-19

Bicyclic pyrazole LRRK2 small molecule inhibitors

#4085
20150051196
2015-02-19

Inhibitors of c-fms kinase

#4086
20150051187
2015-02-19

Substituted pyrazines as ATR kinase inhibitors

#4087
20150051177
2015-02-19

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

#4088
20150051171
2015-02-19

Tetrazolinone compounds and its use as pesticides

#4089
20150045559
2015-02-12

Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics

#4090
20150045393
2015-02-12

Cysteine protease inhibitors and uses thereof

#4091
20150045378
2015-02-12

Aromatic ring compound

#4092
20150045375
2015-02-12

Compounds

#4093
20150045370
2015-02-12

SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder

#4094
20150045365
2015-02-12

Anti-cancer agents

#4095
20150045364
2015-02-12

Pyridine and pyrazine derivative for the treatment of CF

#4096
20150045344
2015-02-12

4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof

#4097
20150045339
2015-02-12

Nitrogen-containing heterocyclic compound or salt thereof

#4098
20150045326
2015-02-12

Pyrazine amide compounds

#4099
20150038516
2015-02-05

Inhibitors of Protein Kinases

#4100
20150038509
2015-02-05

Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy

#4101
20150038488
2015-02-05

Substituted pyrrolidines as SYK inhibitors

#4102
20150038484
2015-02-05

INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK

#4103
20150038481
2015-02-05

Pyrimidine compounds for the treatment of cancer

#4104
20150038416
2015-02-05

GLP-1 receptor modulators

#4105
20150031715
2015-01-29

Integrin antagonist conjugates for targeted delivery to cells expressing VLA-4

#4106
20150031698
2015-01-29

s-Triazine compounds, pharmaceutical compositions and methods of using the same

#4107
20150031690
2015-01-29

Fluoromethyl-5,6-dihydro-4H-[1,3]OXAZINES

#4108
20150031685
2015-01-29

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#4109
20150031679
2015-01-29

Heterocyclic compounds for the inhibition of PASK

#4110
20150031669
2015-01-29

Substituted quinoxalines as FGFR kinase inhibitors

#4111
20150031662
2015-01-29

Useful combinations of monobactam antibiotics with beta-lactamase inhibitors

#4112
20150031661
2015-01-29

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#4113
20150025235
2015-01-22

Benzamide compounds and related methods of use

#4114
20150025114
2015-01-22

Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions

#4115
20150025095
2015-01-22

Diaminopyrimidines and uses thereof

#4116
20150025092
2015-01-22

Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith

#4117
20150025091
2015-01-22

Maleate salts of a quinazoline derivative useful as an antiangiogenic agent

#4118
20150025087
2015-01-22

Azaindole compounds, synthesis thereof, and methods of using the same

#4119
20150025071
2015-01-22

Tetrahydro-quinazolinone derivatives as TANK and PARP inhibitors

#4120
20150025056
2015-01-22

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

#4121
20150025055
2015-01-22

Mutant-selective EGFR inhibitors and uses thereof

#4122
20150024936
2015-01-22

Fungicidal pyrimidine compounds

#4123
20150018551
2015-01-15

Cycloalkane derivatives

#4124
20150018354
2015-01-15

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

#4125
20150018332
2015-01-15

Nuclear transport modulators and uses thereof

#4126
20150018315
2015-01-15

Tetra- and pentasubstituted benzimidazolium compounds

#4127
20150018314
2015-01-15

Benzimidazolium compounds

#4128
20150018313
2015-01-15

5-substituted benzimidazolium compounds

#4129
20150011759
2015-01-08

PROCESSES FOR PREPARING (R)-2-METHYLPYRROLIDINE AND (S)-2-METHYLPYRROLIDINE AND TARTRATE SALTS THEREOF

#4130
20150011752
2015-01-08

Triazine compounds as PI3 kinase and MTOR inhibitors

#4131
20150011575
2015-01-08

Methods and compositions for modulating Ire1, SRC and ABL activity

#4132
20150011561
2015-01-08

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

#4133
20150011553
2015-01-08

Pesticidal arylpyrrolidines

#4134
20150011535
2015-01-08

Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof

#4135
20150011527
2015-01-08

GLP-1 receptor modulators

#4136
20150011002
2015-01-08

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

#4137
20150006445
2015-01-01

Pathway analysis for identification of diagnostic tests

#4138
20150005345
2015-01-01

Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof

#4139
20150005342
2015-01-01

Hepatitis C virus inhibitors

#4140
20150005321
2015-01-01

Indole and azaindole modulators of the alpha 7 nAChR

#4141
20150005319
2015-01-01

Macrocyclic compounds for modulating IL-17

#4142
20150005297
2015-01-01

2,4-pyrimidinediamine compounds and their uses

#4143
20150005294
2015-01-01

Azaheterocyclic compounds

#4144
20150005293
2015-01-01

5-membered heterocyclic amides and related compounds

#4145
20150005281
2015-01-01

PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS KINASE INHIBITORS

#4146
20150005278
2015-01-01

Sulfoximine substituted quinazolines for pharmaceutical compositions

#4147
20150005276
2015-01-01

1,2,4-triazine-4-amine derivatives

#4148
20150000691
2015-01-01

Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses

#4149
20140378683
2014-12-25

CDKI pathway inhibitors and uses thereof

#4150
20140378516
2014-12-25

Compositions, methods of use, and methods of treatment

#4151
20140378488
2014-12-25

4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof

#4152
20140378474
2014-12-25

5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

#4153
20140378464
2014-12-25

Pyrimidinedione compounds

#4154
20140378457
2014-12-25

Inhibitors of c-fms kinase

#4155
20140378442
2014-12-25

Phthalazinone derivatives

#4156
20140378421
2014-12-25

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#4157
20140371467
2014-12-18

Glucagon receptor modulators

#4158
20140371455
2014-12-18

Chemical compounds

#4159
20140371251
2014-12-18

Method of inhibiting DYRK1B

#4160
20140371240
2014-12-18

Insecticidal aromatic amides

#4161
20140371224
2014-12-18

Compounds and compositions for treatment of breathing control disorders or diseases

#4162
20140371222
2014-12-18

Triazole compounds that modulate HSP90 activity

#4163
20140371213
2014-12-18

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

#4164
20140371205
2014-12-18

SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER

#4165
20140371201
2014-12-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#4166
20140371196
2014-12-18

Diamino heterocyclic carboxamide compound

#4167
20140371138
2014-12-18

Inhibitors of hepatitis C virus replication

#4168
20140371068
2014-12-18

N-(1,2,5-oxadiazol-3-yl)-, N-(1,3,4-oxadiazol-2-yl)-, N-(tetrazol-5-yl)-, and N-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides

#4169
20140364626
2014-12-11

Anthracene derivative, light emitting element using the same, and light emitting device using the same

#4170
20140364436
2014-12-11

Protein kinase inhibitors

#4171
20140364431
2014-12-11

Quinoline and cinnoline derivatives and their applications

#4172
20140364410
2014-12-11

Pyrazolopyrimidine compounds as kinase inhibitors

#4173
20140364408
2014-12-11

Hydrazide containing nuclear transport modulators and uses thereof

#4174
20140364392
2014-12-11

Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease

#4175
20140357858
2014-12-04

P2X4 receptor antagonist

#4176
20140357675
2014-12-04

Substituted phenylazole derivatives

#4177
20140357650
2014-12-04

FAP inhibitors

#4178
20140357629
2014-12-04

Diaminopyrimidines as P2Xand P2Xantagonists

#4179
20140357551
2014-12-04

Organic compounds and their uses

#4180
20140350247
2014-11-27

Aryl-amine derivative and organic electroluminescent device using the same as a hole transport material

#4181
20140350036
2014-11-27

Agents that prevent or repair skin damage

#4182
20140350030
2014-11-27

Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same

#4183
20140349997
2014-11-27

Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors

#4184
20140349996
2014-11-27

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#4185
20140349986
2014-11-27

Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof

#4186
20140349921
2014-11-27

HCV NS3 protease inhibitors

#4187
20140343295
2014-11-20

6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors

#4188
20140343278
2014-11-20

Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

#4189
20140343094
2014-11-20

Nitrogen-containing heteroaryl compounds and methods of use thereof

#4190
20140343077
2014-11-20

Hepatitis C inhibitor compounds

#4191
20140343070
2014-11-20

Proton pump inhibitors

#4192
20140343065
2014-11-20

Somatostatin receptor subtype 4 (SSTR4) agonists

#4193
20140343038
2014-11-20

1,2,4-triazine-6-carboxamide derivative

#4194
20140343037
2014-11-20

Benzene, pyridine, and pyridazine derivatives

#4195
20140343018
2014-11-20

Anti-depression compounds

#4196
20140343006
2014-11-20

HIV replication inhibiting pyrimidines

#4197
20140341850
2014-11-20

Haloalkyl heteroaryl benzamide compounds

#4198
20140339462
2014-11-20

Stilbene optical brighteners

#4199
20140336376
2014-11-13

Pharmaceutical composition for treating diabetes

#4200
20140336211
2014-11-13

Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide